AZ-175

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAZ-175
Drug Alias NameAZ-175AZ-121
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHigh affinity immunoglobulin gamma Fc receptor I antagonistsC-reactive protein modulators
TargetsC-reactive proteinHigh affinity immunoglobulin gamma Fc receptor I
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of New Mexico
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAzano BiotechThe University Of New Mexico
Active IndicationsN/A
Inactive IndicationsPurpura, Thrombocytopenic, IdiopathicLupus Nephritis

Other Information

ATC CodeN/A
Related LinksN/A